Patient Square Capital LP
Q1 2026 13F Holdings
- Locationmenlo park, CA
- Num holdings
29
- Value ($000)
$563,607
- Date Filed 05/15/2026
- Form type13F-HR
- CIK 0001819257
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2026 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ROIVANT SCIENCES LTD | SHS | G76279101 | $226.2M | 40 % | 8,166,047 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | $26.81M | 5 % | 36,718 | ||
INSMED INC | COM PAR $.01 | 457669307 | $25.75M | 5 % | 157,500 | ||
BEONE MEDICINES LTD | SPONSORED ADS | 07725L102 | $23.92M | 4 % | 80,542 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | $22.94M | 4 % | 596,000 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | $21.25M | 4 % | 230,000 | ||
BELITE BIO INC | SPONSORED ADS | 07782B104 | $18.6M | 3 % | 116,684 | ||
LEGEND BIOTECH CORP | SPONSORED ADS | 52490G102 | $17.91M | 3 % | 990,000 | ||
NEKTAR THERAPEUTICS | COM NEW | 640268306 | $15.11M | 3 % | 210,000 | ||
DBV TECHNOLOGIES S A | SPONSORED ADS | 23306J309 | $14.49M | 3 % | 693,534 |
Rows Per Page
10
- 10
- 50
- 100